Cloned (Comment) | Organism |
---|---|
gene katG, recombinant expression of wild-type and mutant enzymes in Escherichia coli strain BL21(DE3), subcloning in Escherichia coli strain DH5alpha | Mycobacterium tuberculosis |
Protein Variants | Comment | Organism |
---|---|---|
G421S | site-directed mutagenesis, of amino acids alteration in the mutant, substitution of T354I and G421S create significant instability in the adduct triad complex (Trp107-Tyr229-Met255), a part of the active site of the catalase-peroxidase enzyme in the model structure analysis | Mycobacterium tuberculosis |
additional information | dynamic simulations of enzyme mutants bound to isoniazid (INH) | Mycobacterium tuberculosis |
S140N/A350T/R463L/R463G/L587M | the mutant katG has catalase-peroxidase activities higher than wild-type katG and exhibits INH sensitivity | Mycobacterium tuberculosis |
S315T | naturally occuring mutant, the mutant katG retains peroxidase and catalase activity as 60% and 40%, respectively, from wild-type activity, the mutant develops INH inhibitory levels to the transformant BCG corresponding to the decline of its protein activity | Mycobacterium tuberculosis |
T354I | site-directed mutagenesis, of amino acids alteration in the mutant, substitution of T354I and G421S create significant instability in the adduct triad complex (Trp107-Tyr229-Met255), a part of the active site of the catalase-peroxidase enzyme in the model structure analysis | Mycobacterium tuberculosis |
T354I/G421S/R463L/V721M | naturally occuring mutation. The Mycobacterium tubeculsosis clinical isolate R2 contains four mutations, i.e. C1061T, G1261A, G1388T, G2161A, which correspond to the amino acid substitutions T354I, G421S, R463L, and V721M, respectively, leading to high level isoniazid (INH) resistance. The mutant enzyme showed 86.5% of catalase and 45% of peroxidase activities in comparison to the wild-type enzyme. Substitutions of T354I and G421S in mutant katG R2 create significant instability in the adduct triad complex (Trp107-Tyr229-Met255), a part of the active site of the catalase-peroxidase enzyme in the model structure analysis. Mutant phenotype and stability, overview | Mycobacterium tuberculosis |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Fe2+ | the heme group | Mycobacterium tuberculosis |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
160000 | - |
about | Mycobacterium tuberculosis |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
2 H2O2 | Mycobacterium tuberculosis | - |
O2 + 2 H2O | - |
? | |
2 H2O2 | Mycobacterium tuberculosis H37Rv | - |
O2 + 2 H2O | - |
? | |
2 H2O2 | Mycobacterium tuberculosis ATCC 25618 | - |
O2 + 2 H2O | - |
? | |
isoniazid + H2O2 | Mycobacterium tuberculosis | - |
? | - |
? | |
isoniazid + H2O2 | Mycobacterium tuberculosis H37Rv | - |
? | - |
? | |
isoniazid + H2O2 | Mycobacterium tuberculosis ATCC 25618 | - |
? | - |
? | |
o-dianisidine + H2O2 | Mycobacterium tuberculosis | - |
oxidized o-dianisidine + 2 H2O | - |
? | |
o-dianisidine + H2O2 | Mycobacterium tuberculosis H37Rv | - |
oxidized o-dianisidine + 2 H2O | - |
? | |
o-dianisidine + H2O2 | Mycobacterium tuberculosis ATCC 25618 | - |
oxidized o-dianisidine + 2 H2O | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mycobacterium tuberculosis | P9WIE5 | - |
- |
Mycobacterium tuberculosis ATCC 25618 | P9WIE5 | - |
- |
Mycobacterium tuberculosis H37Rv | P9WIE5 | - |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
2 H2O2 | - |
Mycobacterium tuberculosis | O2 + 2 H2O | - |
? | |
2 H2O2 | peroxidase activity | Mycobacterium tuberculosis | O2 + 2 H2O | - |
? | |
2 H2O2 | - |
Mycobacterium tuberculosis H37Rv | O2 + 2 H2O | - |
? | |
2 H2O2 | peroxidase activity | Mycobacterium tuberculosis H37Rv | O2 + 2 H2O | - |
? | |
2 H2O2 | - |
Mycobacterium tuberculosis ATCC 25618 | O2 + 2 H2O | - |
? | |
2 H2O2 | peroxidase activity | Mycobacterium tuberculosis ATCC 25618 | O2 + 2 H2O | - |
? | |
isoniazid + H2O2 | - |
Mycobacterium tuberculosis | ? | - |
? | |
isoniazid + H2O2 | - |
Mycobacterium tuberculosis H37Rv | ? | - |
? | |
isoniazid + H2O2 | - |
Mycobacterium tuberculosis ATCC 25618 | ? | - |
? | |
o-dianisidine + H2O2 | - |
Mycobacterium tuberculosis | oxidized o-dianisidine + 2 H2O | - |
? | |
o-dianisidine + H2O2 | catalase activity | Mycobacterium tuberculosis | oxidized o-dianisidine + 2 H2O | - |
? | |
o-dianisidine + H2O2 | - |
Mycobacterium tuberculosis H37Rv | oxidized o-dianisidine + 2 H2O | - |
? | |
o-dianisidine + H2O2 | catalase activity | Mycobacterium tuberculosis H37Rv | oxidized o-dianisidine + 2 H2O | - |
? | |
o-dianisidine + H2O2 | - |
Mycobacterium tuberculosis ATCC 25618 | oxidized o-dianisidine + 2 H2O | - |
? | |
o-dianisidine + H2O2 | catalase activity | Mycobacterium tuberculosis ATCC 25618 | oxidized o-dianisidine + 2 H2O | - |
? |
Subunits | Comment | Organism |
---|---|---|
homodimer | 2 * 80000, about SDS-PAGE | Mycobacterium tuberculosis |
More | each subunit has two dominant alpha-helix domains, which means that the domains originated from gene duplication. The N domain has a heme, an active site and a substrate binding site. While the C domain does not have those, its presence is needed to support the overall enzyme activity. The catalytic activity of katG is mediated by some residues in the active site that resided around the heme group | Mycobacterium tuberculosis |
Synonyms | Comment | Organism |
---|---|---|
KatG | - |
Mycobacterium tuberculosis |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
22 | - |
assay at room temperature | Mycobacterium tuberculosis |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
4.5 | - |
peroxidase activity, assay at | Mycobacterium tuberculosis |
7 | - |
catalase activity, assay at | Mycobacterium tuberculosis |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
heme | - |
Mycobacterium tuberculosis |
General Information | Comment | Organism |
---|---|---|
malfunction | mutations of the katG gene in Mycobacterium tuberculosis (T354I, G421S, R463L, and V721M) are a major INH resistance mechanism. The Mycobacterium tuberculosis clinical isolate R2 shows INH resistance at a high level of 0.01 mg/ml | Mycobacterium tuberculosis |
metabolism | to function as an antitubercular agent, INH requires activation of enzyme catalase-peroxidase encoded by Mycobacterium tuberculosis gene katG. The INH is bound by catalase-peroxidase in its active site, then converted to an isonicotinoyl acyl radical through the use of a diazene intermediate. The isonicotinoyl acyl radical interacts with the NADH electron donor in the active site of the enoyl ACP reductase (InhA) enzyme. The NAD-INH complex is known as a potent inhibitor of InhA, the enzyme that has an important role in the biosynthesis of mycolic acid, the cell wall component in mycobacteria | Mycobacterium tuberculosis |
additional information | each subunit has two dominant alpha-helix domains, which means that the domains originated from gene duplication. The N domain has a heme, an active site and a substrate binding site. While the C domain does not have those, its presence is needed to support the overall enzyme activity. The catalytic activity of katG is mediated by some residues in the active site that resided around the heme group. The heme is surrounded by six residues which are Arg104, Trp107 and His108 in the distal pocket, and His270, Trp321 and Asp381 in the proximal pocket. In the heme, the Trp107 residue is connected to Tyr229 and Met255 residues to form an adduct triad complex. The adduct triad is likely conserved in many catalase-peroxidase structures and it is involved in the catalase activity [9]. The binding of INH to katG takes place at the edges of the ?-meso heme. In the region, the residues of the distal pocket, i.e., Arg104, Trp107 and His108, are involved in the interactions with INH. The adduct triad complex (Trp107-Tyr229-Met255) is a part of the active site of the catalase-peroxidase enzyme | Mycobacterium tuberculosis |
physiological function | isoniazid (INH) is a drug for the treatment of tuberculosis in patients infected with Mycobacterium tuberculosis. The katG enzyme, a catalase-peroxidase, encoded by gene katG in Mycobacterium tuberculosis activates the pro-drug INH | Mycobacterium tuberculosis |